Table 1.
Radiographic and clinical parameters in the anteversion, retroversion, and control groups
| Parameter | Dysplastic hip group (100 hips) | Control group (50 hips) | |
|---|---|---|---|
| Anteversion group (83 hips) | Retroversion group (17 hips) | ||
| Femoral anteversion (°) (range) | 22 (−2 to 53)† | 16 (−11 to 40) | 14 (0–37) |
| Acetabular anteversion (°) (range) | 25 (12–37)*,† | 17 (6–25)† | 22 (8–35) |
| Combined anteversion (°) (range) | 47 (22–77)*,† | 30 (4–61) | 36 (19–67) |
| Lateral CE angle (°) (range) | 9 (−24 to 20)† | 13 (1–19)† | 39 (25–55) |
| Sharp angle (°) (range) | 49 (41–59)† | 47 (42–51)† | 36 (29–44) |
| Acetabular roof obliquity (°) (range) | 26 (10–44)*,† | 21 (15–31)† | 2 (−6 to 11) |
| BMI (kg/m2) (range) | 24 (17–31) | 23 (19–35)† | 25 (18–37) |
| Sex (male/female) | 10/73 | 1/16 | 0/50 |
| History of DDH treatment (yes/no) | 18/65 | 1/16 | 0/50 |
Values are expressed as mean with range in parentheses; *significant compared with retroversion group; †significant compared with control group; CE = center-edge; BMI = body mass index; DDH = developmental dysplasia of the hip.